The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALKERMES PLC | SHS | G01767105 | 326,570 | 14,040,000 | SH | SOLE | 14,040,000 | 0 | 0 | ||
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 64,873 | 19,250,000 | SH | SOLE | 19,250,000 | 0 | 0 | ||
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 55,948 | 4,039,600 | SH | SOLE | 4,039,600 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 154,269 | 643,000 | SH | SOLE | 643,000 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558103 | 209,792 | 2,889,300 | SH | SOLE | 2,889,300 | 0 | 0 | ||
| INNOVIVA INC | COM | 45781M101 | 114,092 | 6,614,000 | SH | SOLE | 6,614,000 | 0 | 0 | ||
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 191,107 | 16,390,000 | SH | SOLE | 16,390,000 | 0 | 0 | ||
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 26,742 | 4,299,297 | SH | SOLE | 4,299,297 | 0 | 0 | ||
| PEAR THERAPEUTICS INC | CLASS A COM | 704723105 | 3,102 | 500,356 | SH | SOLE | 500,356 | 0 | 0 | ||
| REGULUS THERAPEUTICS INC | COM NEW | 75915K200 | 583 | 1,851,851 | SH | SOLE | 1,851,851 | 0 | 0 | ||
| VOR BIOPHARMA INC | COM | 929033108 | 8,215 | 707,010 | SH | SOLE | 707,010 | 0 | 0 | ||